Carson Wealth (CWM LLC)
LUMO

Carson Wealth (CWM LLC)’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11
Closed – – 4511
2023
Q1 		$0 Buy
+11
New +$38 ﹤0.01% 4392

Other funds holding LUMO

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return

Carson Wealth (CWM LLC)'s LUMO Position: Q2 2023 in Review

Carson Wealth (CWM LLC) sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2023, closing a stake of 11 shares.

Carson Wealth (CWM LLC) first reported a position in LUMO in Q1 2023 and held it in 1 quarter. The position peaked at $0 in Q1 2023. 34 funds tracked by Wall St. Rank hold LUMO as of Q2 2023.

  • Carson Wealth (CWM LLC) reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 11 Lumos Pharma, Inc. Common Stock shares in Q2 2023.
  • Carson Wealth (CWM LLC) first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Carson Wealth (CWM LLC)'s Lumos Pharma, Inc. Common Stock position peaked at $0 in Q1 2023.
  • 34 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2023.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2023, filed 3 Aug 2023.